SensoDetect operates in the healthcare sector. The company specializes in developing medical equipment that is used to analyze how a patient's brain reacts to sound stimuli. The technology is used in psychiatry to distinguish potential mental illnesses. The product consists of electrodes that are attached to the patient's head and then analyze brain activity. The results are compared against a database for further analysis. SensoDetect was founded in 2005 and is headquartered in Lund.

Quotes for SensoDetect AB

Right Now

+/-
0.034
%
6,42%
Latest
0.564
High
0.582
Low
0.516
Volume
688 551
Turnover (SEK)
382 421
Market Value (MSEK)
249,4
Time (Latest trade)
2025-09-19 15:30

Board

CEO

  • Per-Anders Hedin

Chairperson of the Board

  • Johan Möllerström

Board

  • Pia Kinhult
  • Tore Robertsson
  • Wendi Ma
  • Articles of association

    • News

    Show More

    News agencies

    Show More

    Analysis

    Videos

    SensoDetect - Stora Aktiedagarna Stockholm 28 november 2024

    SensoDetect

    SensoDetect - Presentation BioStock Live - 2018-11-27

    SensoDetect AB intervju

    Largest Owners

    Name Capital % Votes % Date
    Thomas Erik Frithiof Holmgren 15,18 15,18 2025-06-26
    Nordnet Pensionsförsäkring 8,96 8,96 2025-06-26
    Nowo Fund Management AB 7,20 7,20 2025-08-31
    Karl Vilhelm Gustaf Lundin 3,74 3,74 2025-06-26
    Avanza Pension 3,48 3,48 2025-06-26
    Tore Robertsson 3,14 3,14 2025-06-26
    Johan Möllerström med bolag 3,05 3,05 2025-06-26
    Per-Anders Hedin 2,96 2,96 2025-07-07
    Joachim Runesson 2,18 2,18 2025-06-26
    Birgitta Möllerström 2,09 2,09 2025-06-26
    ** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

    Upcoming reports

    • 2025-11-11 Delårsrapport 2025-Q3

    • 2026-02-20 Bokslutskommuniké 2025

    Annual reports, prospectus etc.